Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 140

Similar articles for PubMed (Select 10227086)

1.

Effect of a selective dopamine D1 agonist (ABT-431) on smoked cocaine self-administration in humans.

Haney M, Collins ED, Ward AS, Foltin RW, Fischman MW.

Psychopharmacology (Berl). 1999 Mar;143(1):102-10.

PMID:
10227086
2.

Effects of ecopipam, a selective dopamine D1 antagonist, on smoked cocaine self-administration by humans.

Haney M, Ward AS, Foltin RW, Fischman MW.

Psychopharmacology (Berl). 2001 Jun;155(4):330-7.

PMID:
11441422
3.
4.

Effects of the novel D1 dopamine receptor agonist ABT-431 on cocaine self-administration and reinstatement.

Self DW, Karanian DA, Spencer JJ.

Ann N Y Acad Sci. 2000;909:133-44.

PMID:
10911927
5.

Alternative reinforcers differentially modify cocaine self-administration by humans.

Hart CL, Haney M, Foltin RW, Fischman MW.

Behav Pharmacol. 2000 Feb;11(1):87-91.

PMID:
10821213
6.

Effects of pergolide on intravenous cocaine self-administration in men and women.

Haney M, Foltin RW, Fischman MW.

Psychopharmacology (Berl). 1998 May;137(1):15-24.

PMID:
9631952
7.
8.

Enadoline and butorphanol: evaluation of kappa-agonists on cocaine pharmacodynamics and cocaine self-administration in humans.

Walsh SL, Geter-Douglas B, Strain EC, Bigelow GE.

J Pharmacol Exp Ther. 2001 Oct;299(1):147-58.

9.
10.

Effects of chronic administration of the D1 receptor partial agonist SKF 77434 on cocaine self-administration in rhesus monkeys.

Mutschler NH, Bergman J.

Psychopharmacology (Berl). 2002 Apr;160(4):362-70. Epub 2002 Feb 12.

PMID:
11919663
11.

Self-administration of cocaine by humans: choice between smoked and intravenous cocaine.

Foltin RW, Fischman MW.

J Pharmacol Exp Ther. 1992 Jun;261(3):841-9.

PMID:
1602388
12.

Repeated administration of the D1/5 antagonist ecopipam fails to attenuate the subjective effects of cocaine.

Nann-Vernotica E, Donny EC, Bigelow GE, Walsh SL.

Psychopharmacology (Berl). 2001 Jun;155(4):338-47.

PMID:
11441423
13.

Effects of dopamine D(1-like) and D(2-like) agonists in rats that self-administer cocaine.

Caine SB, Negus SS, Mello NK, Bergman J.

J Pharmacol Exp Ther. 1999 Oct;291(1):353-60.

14.

Binge cocaine self-administration by humans: smoked cocaine.

Ward AS, Haney M, Fischman MW, Foltin RW.

Behav Pharmacol. 1997 Dec;8(8):736-44.

PMID:
9832960
15.

Modulation of cocaine and food self-administration by low- and high-efficacy D1 agonists in squirrel monkeys.

Platt DM, Rowlett JK, Spealman RD.

Psychopharmacology (Berl). 2001 Sep;157(2):208-16.

PMID:
11594448
16.

Interactions between cocaine and dopamine agonists on cardiovascular function in squirrel monkeys.

Schindler CW, Gilman JP, Bergman J, Mello NK, Woosley RL, Goldberg SR.

J Pharmacol Exp Ther. 2002 Jan;300(1):180-7.

17.

Physiological, subjective and reinforcing effects of oral and intravenous cocaine in humans.

Smith BJ, Jones HE, Griffiths RR.

Psychopharmacology (Berl). 2001 Aug;156(4):435-44.

PMID:
11498721
18.

The effects of memantine on the subjective, reinforcing and cardiovascular effects of cocaine in humans.

Collins ED, Ward AS, McDowell DM, Foltin RW, Fischman MW.

Behav Pharmacol. 1998 Nov;9(7):587-98.

PMID:
9862084
19.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk